Glia-neuron interaction in fetal alcohol spectrum disorders
Project Number5I01BX001819-08
Former Number2I01BX000819-06
Contact PI/Project LeaderGUIZZETTI, MARINA
Awardee OrganizationPORTLAND VA MEDICAL CENTER
Description
Abstract Text
Substance use disorders are common among women veterans, many of which are of childbearing age.
Drinking during pregnancy may lead to Fetal Alcohol Spectrum Disorders (FASD), a leading cause of
intellectual disability. Research on novel mechanisms involved in FASD, which may lead to innovative
interventions, is therefore a topic highly relevant to the VA mission. Hippocampal alterations are associated
with deficits in learning and memory in individuals with FASD. The extracellular matrix (ECM) plays a major
role in brain development and astrocytes are major regulators of the brain ECM. Critical gaps in knowledge
remain concerning the mechanisms by which ethanol alters neuronal development in the fetal hippocampus
hampering the development of therapies for FASD. Indeed, there is no published literature on the effects of
alcohol exposure during the third trimester of human gestation-equivalent on astrocyte gene expression in vivo.
Furthermore, dysregulation of the brain ECM mediated by alterations in extracellular proteases is involved in
many neuropathological conditions and in addiction. However, very little is known about the role of the ECM
and extracellular proteases in FASD in vivo. Finally, the link between changes in astrocyte-released ECM
modulators and dendritic development following neonatal alcohol exposure has not been investigated.
Preliminary results suggest that developmental alcohol exposure alters the ECM through the modulation of
extracellular protease systems in the hippocampus. Indeed, Adamts5 expression, encoding for a disintegrin
and metalloproteinase with thrombospondin motifs 5 (ADAMTS5), a protease that degrades lecticans, and
tissue plasminogen activator (tPA), which can activate ADAMTSs, are both upregulated in the hippocampus of
animals neonatally exposed to ethanol. Furthermore, we observed decreased levels of lectican sulfated
glycosaminoglycans (sGAGs) and increased proteolysis of the lectican brevican in these animals. We also
observed down-regulation of Mmp14 and Mmp15 encoding for matrix metalloproteinases (MMP)14 and
MMP15 and increased protein levels of one major target of these MMPs: laminin. All of these changes are
consistent with an ethanol-induced increase in dendritic arborization in pyramidal hippocampal neurons, as
lecticans are inhibitors and laminin is a strong inducer of dendritic arborization. The overall hypothesis of this
proposal is that ethanol alters the expression and activity of astrocyte extracellular proteases leading to ECM
remodeling and increased dendritic arborization in the hippocampus. In aim 1, the hypothesis that
developmental ethanol exposure increases the expression and activity of ADAMTSs that degrade lecticans in
part via an increase in tPA expression leading to ADAMTS activation resulting in the degradation of lecticans
and increased dendritic arborization in the neonatal brain will be explored. In aim 2, the hypothesis that ethanol
exposure decreases MMP14 and MMP15 leading to increased laminin protein levels and increased dendritic
complexity will be explored. Aims 1 and 2 will employ qRT-PCR, Western blot, confocal microscopy, Golgi-Cox
staining followed by morphometric analysis with the software Neurolucida, and AAV6 viral construct injections
into the hippocampus to overexpress ADAMTS5 and tPA and to silence MMP14 and MMP15. In aim 3 the
modulation of gene expression by ethanol in neonatal hippocampal astrocytes of Aldh1l1-EGFP-Rpl10a mice
using the translating ribosome affinity purification (TRAP) methodology will be examined. The effects of
neonatal alcohol exposure on the expression of target genes encoding for ECM proteins and proteins involved
in the remodeling of the ECM as well as on astrocyte global gene expression will be analyzed. We will isolate
astrocyte mRNA in the engineered Aldh1l1-EGFP-Rpl10a mouse model that expresses a modified ribosomal
protein Rpl10a with an eGFP tag (EGFP-Rpl10a) in cells expressing Aldh1l1 (a highly specific astrocytic
marker) using the TRAP method. This study will unveil novel astrocyte-mediated effects of ethanol on
extracellular proteases leading to changes in ECM composition and neuronal development.
Public Health Relevance Statement
Women are playing a growing role in the U.S. military and women are the fastest growing group of new users
of the VA health care system. Between 2005 and 2015 the number of women veterans enrolled in the VA
health care system increased 84%. Alcohol abuse in reproductive-age women represents a particularly severe
problem because in utero alcohol exposure can cause FASD, a leading cause of intellectual and behavioral
disabilities. Approximately 50% of women veterans enrolled in the VA health care system are of childbearing
age. Recent studies reported that 25% of women veterans have unhealthy alcohol use. This study will unveil
novel astrocyte-mediated effects of ethanol on extracellular proteases leading to changes in ECM composition
and neuronal development. A better understanding of these effects of alcohol will lead to therapeutic
interventions that are not only specific for a given molecular target, but also for a given cellular target and, for
this reason, safer. The proposed studies are an essential first step towards achieving this goal.
No Sub Projects information available for 5I01BX001819-08
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5I01BX001819-08
Patents
No Patents information available for 5I01BX001819-08
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5I01BX001819-08
Clinical Studies
No Clinical Studies information available for 5I01BX001819-08
News and More
Related News Releases
No news release information available for 5I01BX001819-08
History
No Historical information available for 5I01BX001819-08
Similar Projects
No Similar Projects information available for 5I01BX001819-08